Cargando…
Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
Circulating anti-p53 antibodies have been described and used as tumoural markers in patients with various cancers and strongly correlate with the p53 mutated status of the tumours. No study has yet looked at the prevalence of such antibodies in skin carcinoma patients although these tumours have bee...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364020/ https://www.ncbi.nlm.nih.gov/pubmed/11747330 http://dx.doi.org/10.1054/bjoc.2001.2185 |